Annual SGA
$41.32 M
+$2.40 M+6.16%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual SGA is $41.32 million, with the most recent change of +$2.40 million (+6.16%) on December 31, 2023.
- During the last 3 years, STOK annual SGA has risen by +$20.48 million (+98.22%).
- STOK annual SGA is now at all-time high.
Performance
STOK SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$12.69 M
-$345.00 K-2.65%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly SGA is $12.69 million, with the most recent change of -$345.00 thousand (-2.65%) on September 30, 2024.
- Over the past year, STOK quarterly SGA has increased by +$2.42 million (+23.57%).
- STOK quarterly SGA is now -2.65% below its all-time high of $13.04 million, reached on June 30, 2024.
Performance
STOK Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.76 B
-$105.46 M-6.36%
September 30, 2024
Summary
- As of February 7, 2025, STOK TTM SGA is -$1.76 billion, with the most recent change of -$105.46 million (-6.36%) on September 30, 2024.
- Over the past year, STOK TTM SGA has dropped by -$1.80 billion (-4500.28%).
- STOK TTM SGA is now -6762.46% below its all-time high of -$25.71 million.
Performance
STOK TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
STOK Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.2% | +23.6% | -4500.3% |
| 3 y3 years | +98.2% | +23.6% | -4500.3% |
| 5 y5 years | +837.0% | +23.6% | -4500.3% |
STOK Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.6% | -2.6% | +45.5% | -174.0% | at low |
| 5 y | 5-year | at high | +246.8% | -2.6% | +219.0% | -898.9% | at low |
| alltime | all time | at high | +2012.6% | -2.6% | +1823.0% | -6762.5% | at low |
Stoke Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.69 M(-2.6%) | $46.56 M(+5.5%) |
| Jun 2024 | - | $13.04 M(+27.6%) | $44.14 M(+6.8%) |
| Mar 2024 | - | $10.22 M(-3.7%) | $41.33 M(+0.0%) |
| Dec 2023 | $41.32 M(+6.2%) | $10.61 M(+3.3%) | $41.32 M(+3.1%) |
| Sep 2023 | - | $10.27 M(+0.4%) | $40.10 M(+0.8%) |
| Jun 2023 | - | $10.23 M(+0.2%) | $39.77 M(+0.3%) |
| Mar 2023 | - | $10.21 M(+8.8%) | $39.65 M(+1.9%) |
| Dec 2022 | $38.92 M(+22.0%) | $9.38 M(-5.6%) | $38.92 M(+1.7%) |
| Sep 2022 | - | $9.94 M(-1.7%) | $38.27 M(+4.4%) |
| Jun 2022 | - | $10.11 M(+6.6%) | $36.65 M(+6.3%) |
| Mar 2022 | - | $9.49 M(+8.7%) | $34.47 M(+8.1%) |
| Dec 2021 | $31.90 M | $8.72 M(+4.8%) | $31.90 M(+10.5%) |
| Sep 2021 | - | $8.32 M(+4.9%) | $28.86 M(+10.4%) |
| Jun 2021 | - | $7.93 M(+14.8%) | $26.13 M(+12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $6.91 M(+21.7%) | $23.24 M(+11.5%) |
| Dec 2020 | $20.85 M(+75.0%) | $5.68 M(+1.4%) | $20.85 M(+8.9%) |
| Sep 2020 | - | $5.60 M(+11.1%) | $19.14 M(+13.5%) |
| Jun 2020 | - | $5.04 M(+11.6%) | $16.87 M(+18.4%) |
| Mar 2020 | - | $4.52 M(+13.6%) | $14.24 M(+19.6%) |
| Dec 2019 | $11.91 M(+170.2%) | $3.98 M(+19.7%) | $11.91 M(+25.8%) |
| Sep 2019 | - | $3.32 M(+37.2%) | $9.47 M(+30.9%) |
| Jun 2019 | - | $2.42 M(+10.6%) | $7.24 M(+21.9%) |
| Mar 2019 | - | $2.19 M(+42.3%) | $5.94 M(+34.7%) |
| Dec 2018 | $4.41 M(+125.5%) | $1.54 M(+41.1%) | $4.41 M(+53.6%) |
| Sep 2018 | - | $1.09 M(-2.9%) | $2.87 M(+61.2%) |
| Jun 2018 | - | $1.12 M(+70.0%) | $1.78 M(+170.0%) |
| Mar 2018 | - | $660.00 K | $660.00 K |
| Dec 2017 | $1.96 M | - | - |
FAQ
- What is Stoke Therapeutics annual SGA?
- What is the all time high annual SGA for Stoke Therapeutics?
- What is Stoke Therapeutics annual SGA year-on-year change?
- What is Stoke Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly SGA year-on-year change?
- What is Stoke Therapeutics TTM SGA?
- What is the all time high TTM SGA for Stoke Therapeutics?
- What is Stoke Therapeutics TTM SGA year-on-year change?
What is Stoke Therapeutics annual SGA?
The current annual SGA of STOK is $41.32 M
What is the all time high annual SGA for Stoke Therapeutics?
Stoke Therapeutics all-time high annual SGA is $41.32 M
What is Stoke Therapeutics annual SGA year-on-year change?
Over the past year, STOK annual SGA has changed by +$2.40 M (+6.16%)
What is Stoke Therapeutics quarterly SGA?
The current quarterly SGA of STOK is $12.69 M
What is the all time high quarterly SGA for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly SGA is $13.04 M
What is Stoke Therapeutics quarterly SGA year-on-year change?
Over the past year, STOK quarterly SGA has changed by +$2.42 M (+23.57%)
What is Stoke Therapeutics TTM SGA?
The current TTM SGA of STOK is -$1.76 B
What is the all time high TTM SGA for Stoke Therapeutics?
Stoke Therapeutics all-time high TTM SGA is -$25.71 M
What is Stoke Therapeutics TTM SGA year-on-year change?
Over the past year, STOK TTM SGA has changed by -$1.80 B (-4500.28%)